These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 4740976

  • 1. Depletion of brain norepinephrine by intraventricular injection of 6-hydroxydopa: a biochemical, histochemical and behavioral study in rats.
    Richardson JS, Jacobowitz DM.
    Brain Res; 1973 Aug 17; 58(1):117-33. PubMed ID: 4740976
    [No Abstract] [Full Text] [Related]

  • 2. Regional differences in the long-term effect of neonatal 6-hydroxydopa treatment on rat brain noradrenaline.
    Zieher LM, Jaim-Etcheverry G.
    Brain Res; 1973 Sep 28; 60(1):199-207. PubMed ID: 4744760
    [No Abstract] [Full Text] [Related]

  • 3. [Modification of the metabolism of cerebral serotonin (5-HT) induced in rats by the administration of 6-hydroxydopamine].
    Blondaux C, Juge A, Sordet F, Chouvet G, Jouvet M, Pujol JF.
    Brain Res; 1973 Feb 14; 50(1):101-14. PubMed ID: 4690541
    [No Abstract] [Full Text] [Related]

  • 4. Altered ontogenesis of central noradrenergic neurons following neonatal treatment with 6-hydroxydopamine.
    Singh B, Champlain J.
    Brain Res; 1972 Dec 24; 48():432-7. PubMed ID: 4645216
    [No Abstract] [Full Text] [Related]

  • 5. Effects of morphine on cat brain norepinephrine in regions with daily monoamine rhythms.
    Reis DJ, Rifkin M, Corvelli A.
    Eur J Pharmacol; 1969 Oct 24; 8(1):149-52. PubMed ID: 5357071
    [No Abstract] [Full Text] [Related]

  • 6. Behavioural and biochemical effects of 6-hydroxydopa in rats.
    Kmieciak-Kolada K, Herman ZS, Slomińska-Zurek J.
    Psychopharmacologia; 1974 Mar 09; 35(4):341-52. PubMed ID: 4857558
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of spinal cord transection and intracisternal 6-hydroxydopamine on phenylethanolamine-N-methyl transferase (PNMT) activity in rat brain stem and spinal cord.
    Reid JL, Zivin JA, Kopin IJ.
    J Neurochem; 1976 Mar 09; 26(3):629-31. PubMed ID: 1063254
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Axoplasmic transport of norepinephrine in the rat brain.
    Levin BE, Sadowsky CH, Stolk JM.
    Life Sci; 1976 Apr 15; 18(8):837-40. PubMed ID: 58362
    [No Abstract] [Full Text] [Related]

  • 17. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW, Sparber SB.
    J Pharmacol Exp Ther; 1974 Dec 15; 191(3):349-57. PubMed ID: 4427285
    [No Abstract] [Full Text] [Related]

  • 18. [Feeding behavior in sheep: effects of nialamide and 6-hydroxydopamine (author's transl)].
    Croze S, Bost J.
    Psychopharmacologia; 1974 Dec 15; 40(3):259-68. PubMed ID: 4445452
    [No Abstract] [Full Text] [Related]

  • 19. Development of the blood-brain barrier for 6-hydroxydopamine.
    Sachs C.
    J Neurochem; 1973 Jun 15; 20(6):1753-60. PubMed ID: 4719317
    [No Abstract] [Full Text] [Related]

  • 20. 6-Hydroxydopamine during development: relation between opposite regional changes in brain noradrenaline.
    Zieher LM, Jaim-Etcheverry G.
    Eur J Pharmacol; 1979 Oct 01; 58(3):217-23. PubMed ID: 510355
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.